New technique for treating pancreatic cancer using Whipple surgery
Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study
This study is testing a new surgical technique for treating pancreatic cancer to see if it can help patients keep more of their pancreas and do better than the standard surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 70 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06119776 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the safety and efficacy of a novel surgical technique called Whipple over the splenic artery (WOTSA) as an alternative to total pancreatectomy (TP) for patients with pancreatic ductal adenocarcinoma (PDCA). The study involves 40 patients who underwent WOTSA, comparing their outcomes with a historical control group of 30 patients who had TP. The goal is to determine if WOTSA can effectively preserve more pancreatic tissue and improve patient outcomes compared to the traditional approach.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with pancreatic ductal cell adenocarcinoma who are eligible for surgical intervention.
Not a fit: Patients undergoing palliative pancreatectomy or those with distant metastases or other malignancies will not benefit from this study.
Why it matters
Potential benefit: If successful, this technique could lead to better preservation of pancreatic function and improved survival rates for patients with pancreatic cancer.
How similar studies have performed: While similar surgical techniques have been explored, this specific approach is novel and has not been widely tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * pancreatic ductal cell adenocarcinoma (PDCA) patients Exclusion Criteria: * Patient undergoing palliative pancreatectomy, other malignancies with distant metastases * Vulnerable groups
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Ting-Chun Kuo
- Email: tinakuo1204@gmail.com
- Phone: +88623123456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.